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Indeed., several studies (15) have showu that extent of 
~omm-y atherosclerosis i  greater indiabetic than in non- 
rate in these men was higher on 
in survival both in the hospital and after discharge. This was 
evident even when the main ep miologic haracteristics of 
insulin-dependent diabetic w w and men were largely 
The possibility cannot be excluded that his result merely 
represents a chance ~beo~~eno~ dueto t 
group analysis, and the data may vary ford 
patients because of the wide ce intervals for the 
group with insulin-dependent and the low prevs- 
lence of this disease in men. However, the differences 
observed for in-hospital mortality were co med after 
correcting for several epidemiologic and clit~ieal \,,xiables 
st twice as high in wo 
The scarcity OF data on t 
may be required in these patients. 
1989;3S:350-7. 
4. Savage MP, Krokwski AS, Kenien CG, ‘L&is MP, Christtieh AH. 
~cwis SM. Acute myocardial nfarctjon i diabdcs meMus and dgti- 
cance of congestive heart failure as a prognostic factor. Am J Cardiol 
5. Jamby RM, Nesto RW. Acute myocardial infarction in the diabetic 
patient: pathophysiolagy, clinicat course and prognosis. J Am Coil 
6. Greenland P. Reichcr-kiss H, Mdbourt U, Behar S. in-hospital and 
l-y= mortality in 1324 women after myocardial infarction: comparison 
with4315 arm, Circulation 1991;83:4154-91. 
7, Gmppo bkno per lo Studio delh Soprawivenzsl nell’lnftio Mio- 
GlSSl-2: a f&xial random&d trial of aiteplase v rsus trep 
a4 hqarin versus M) heparin among 12 490 patients with acute 
Lilnm 19?%336:65-‘91. 
8, 
9, 
10, 
II, 
